Equities

Althea Group Holdings Ltd

Althea Group Holdings Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.026
  • Today's Change0.00 / 0.00%
  • Shares traded307.53k
  • 1 Year change-39.53%
  • Beta1.8684
Data delayed at least 20 minutes, as of Jul 05 2024 03:38 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Althea Group Holdings Limited is engaged in the manufacturing, sales and distribution of recreational cannabis products and cannabis-based medicines. The Company operates through three business units: Althea, MyAccess Clinics and Peak Processing Solutions. Althea and MyAccess Clinics service the international pharmaceutical cannabis market, whilst Peak Processing Solutions operates in the federally legal Canadian recreational cannabis market. The Company’s segments include the international pharmaceutical segment (Pharmaceutical Cannabis), the Canadian recreational segment (Recreational Cannabis) and the shared corporate services (Corporate). The Pharmaceutical Cannabis includes Althea, a brand of cannabis-based medicine. The Company’s Recreational Cannabis segment includes Peak Processing Solutions (Peak), a contract manufacturing organization which works with consumer-packaged goods companies to develop, manufacture, and distribute recreational cannabis products.

  • Revenue in AUD (TTM)28.70m
  • Net income in AUD-20.99m
  • Incorporated2018
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Hydration Pharmaceuticals Co Ltd14.93m-12.04m2.74m--------0.1839-0.0618-0.06180.0765-0.0021.181.616.60---94.86-79.98-143.75-111.5753.7048.73-80.69-99.531.37-21.481.10--10.3419.2723.61------
Epsilon Healthcare Ltd7.21m-5.93m7.21m----0.7868--0.9994-0.0198-0.01980.02410.03050.383917.942.73---31.54-35.68-46.30-41.1137.9926.88-82.17-197.560.5237-9.280.2329--29.3630.99-43.77--8.14--
Anatara Lifesciences Ltd0.00-1.75m7.65m----5.30-----0.014-0.0140.000.00760.00-------103.15-59.64-115.72-66.52-------1,927.05----0.00------20.10---40.49--
Nyrada Inc3.08m-4.98m10.20m----1.91--3.31-0.0319-0.03190.01980.02940.3983-------64.37-64.90-71.93-84.66-----161.62-380.62---15,086.390.00--42.54229.09-96.52------
TrivarX Ltd20.81k-3.74m10.24m4.00--1.01--492.13-0.0182-0.01820.000090.02490.0023-------42.02-41.56-47.15-50.51100.0092.74-17,949.78-334.16---147.210.0072---4.69-18.0675.85------
Firebrick Pharma Ltd0.00-4.57m10.35m----5.94-----0.0266-0.02660.000.00890.00-------120.70---136.04----------4.37--0.00---79.85---79.18------
Althea Group Holdings Ltd28.70m-20.99m10.54m----0.6874--0.3672-0.059-0.0590.07960.03780.61812.475.53---45.22-31.09-66.73-36.3254.6450.76-73.15-101.390.4899-46.550.2756--22.43335.18-13.21------
Argent BioPharma Ltd1.32m-17.02m13.13m----7.81--9.91-3.32-3.320.10030.03720.08130.70781.58---105.32-111.29-345.98-171.0521.8732.52-1,295.20-632.420.6561-24.850.4104---28.4147.31-2.34---16.20--
Auscann Group Holdings Ltd2.05m-9.44m17.51m27.00------8.55-0.0213-0.02170.00430.01620.1674--5.35---77.15-39.85-78.72-40.73100.59---460.74-925.91---23.160.00--13.8851.3757.10------
Acrux Ltd14.46m-709.00k18.32m43.00--3.24--1.27-0.0024-0.00240.05020.01951.29--4.86---6.34-39.91-9.21-46.0072.38---4.90-132.53----0.2861--133.7428.2992.23---16.66--
Calmer Co International Ltd2.46m-4.50m18.38m--------7.47-0.0083-0.00830.0039-0.00050.6551.349.62---119.81-139.15-231.33-198.5536.0330.26-182.94-388.810.482-9.361.22---13.00239.4311.40------
Oncosil Medical Ltd355.30k-11.71m19.99m2.00--3.07--56.27-0.0081-0.00810.00020.0020.0506--7.88---166.55-57.65-234.81-64.83-426.96---3,295.08-473.02---68.930.0256---59.92-37.72-5.74--40.13--
Immuron Ltd3.58m-3.88m20.06m6.00--1.14--5.61-0.017-0.0170.01570.07690.16640.64687.92596,106.70-18.06-27.48-19.86-29.5880.8777.52-108.52-296.647.79-2.850.0023--135.85-13.34-32.66--3.27--
Data as of Jul 05 2024. Currency figures normalised to Althea Group Holdings Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.